Acorda Therapeutics, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Acorda Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2019-09-30 was $0.00.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2019-06-30 was $39.00K, a 89.87% decline year-over-year.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2019-03-31 was $52.00K, a 95.67% decline year-over-year.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for fiscal 2019 was $91.00K, a 94.78% decline from fiscal 2018.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for fiscal 2018 was $1.74M, a 2806.67% increase from fiscal 2017.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for fiscal 2017 was $60.00K.
- Acorda Therapeutics, Inc. payments for repurchase of common stock for fiscal 2010 was $329.00K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $91.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $248.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $248.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $52.00K 10-Q · filed 2020-05-08 | $594.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.74M 10-K · filed 2020-02-28 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.59M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $385.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.59M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $1.20M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $60.00K 10-K · filed 2020-02-28 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | |
| 2010-12-31 | $329.00K 10-K · filed 2013-02-28 |